We are live on
!
Find out more
AP
AGTC Partners Portfolio holdings
AUM
$13.6M
1-Year Est. Return
15.62%
This Fund
S&P 500
This Quarter
Est. Return
+26%
1 Year Est. Return
-15.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.1M
AUM Growth
–
Cap. Flow
+$19.8M
Cap. Flow
% of AUM
89.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$18.5M |
| 2 |
BGMD
BG MEDICINE INC COM STK NEW
BGMD
|
+$1.28M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.61% |
Similar funds
LS
IACGFA
AC
SFM
SC
NCMC
EAM
NGPI
AGTC Partners's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for AGTC Partners, which disclosed 2 positions worth $22.1M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Acceleron Pharma: 530,919 shares worth $20.7M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets.
- AGTC Partners's largest Q4 2014 buy was Acceleron Pharma: 530,919 shares worth $20.7M.
- AGTC Partners's ten largest holdings make up 100% of its $22.1M portfolio in Q4 2014.
- AGTC Partners disclosed 2 positions in Q4 2014, its first 13F filing on record.
Based on AGTC Partners's 13F filing for Q4 2014, filed 12 Feb 2015.